Quent Capital LLC reduced its position in United Therapeutics Co. ( NASDAQ:UTHR – Get Rating ) by 31.7% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 4,223 shares of the biotechnology company's stock after selling 1,962 shares during the period. Quent Capital LLC's holdings in United Therapeutics were worth $929,000 at the end of the most recent quarter. Other large investors have also made changes to their positions in the company. Baldwin Brothers LLC MA purchased a new position in United Therapeutics in the fourth quarter valued at about $38,000.

https://www.dailypolitical.com/2023/06/17/quent-capital-llc-cuts-holdings-in-united-therapeutics-co-nasdaquthr.html

#dailypolitical